Arcus’s lead program targets the adenosine pathway, which has been shown to play a significant role in driving immuno-suppression in the tumor micro-environment.
Developing drugs to treat central nervous system disorders.
Ascentage is a globally-focused clinical-stage biopharmaceutical company developing targeted therapeutics for cancers, hepatitis B & age-related diseases using small molecules that target ...
Contract Small Molecules
Assembly Biosciences is advancing a new class of oral therapeutics for the treatment of hepatitis B (HBV) infection and novel oral biotherapeutics for disorders associated with the microbiome.
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.
A biopharmaceutical company that focuses on Cardiovascular and Metabolic diseases, Oncology, and Respiratory, Inflammation and Autoimmunity, Infection, Neuroscience and Gastrointestinal diseases, ...
Small molecule, peptide and peptidomimetic modulators
The company has a novel platform of disease-modifying regenerative small molecules, particularly relevant to neurodegenerative ...
Attix Pharmaceuticals designs and sells active pharmaceutical ingredients and ingredients for nutraceuticals, and food, for both human and veterinary applications.
Attune Pharmaceuticals is a private biotechnology company focused on discovering and developing novel orally-administered small-molecule therapeutics for the treatment of rare diseases.
Small Molecules & Biologics
AVEO Oncology (AVEO) is a biopharmaceutical company dedicated to advancing a broad portfolio of targeted therapeutics for oncology and other areas of unmet medical need.
Small Molecules for stress, mood, behavior